The largest database of trusted experimental protocols
> Procedures > Therapeutic or Preventive Procedure > Patient Care Bundles

Patient Care Bundles

Patient Care Bundls: Optimizing Patient Outcomes Through Coordinated Interventions.
Patient Care Bundles are evidence-based sets of interventions that, when implemented together, improve patient care and outcomes.
These bundls typicaly include a collection of best practices targeting specific clinical conditions or care processes.
By applying a bundled approach, healthcare providers can enhance patient safety, reduce complications, and promote better overall health.
PubCompare.ai's innovative platform enables seamless research and identification of the most effective Patient Care Bundls from literature, pre-prints, and patents, helping to drive improved patient outcomes.

Most cited protocols related to «Patient Care Bundles»

Patients diagnosed as mild cognitive impairment or dementia at memory clinic from October 2015 to April 2017 in Changhua Christian Hospital were enrolled. The clinical trial was approved by the Institutional Review Board of Changhua Christian Hospital (CCH IRB 160165). Because the design of the present study was a retrospective chart review, informed consent was waived by the Institutional Review Board of Changhua Christian Hospital. All data were recorded in the electronic medical chart with the highest confidentiality and compliance with the Declaration of Helsinki. Six hundred and eight patients who received team-approached assessment were screened, and after excluding those with incomplete data and those with a dementia subtype including fewer than 10 registered patients, the remaining 508 were included for analysis. The demographic information including gender, age, type of dementia, and clinical dementia rating (CDR) is summarized in Table 2. A majority of the patients were women (66%) with Alzheimer’s disease (72%) aged 75 years and older (82%) who had mild dementia (51%). National Institute on Aging-Alzheimer’s Association (NIA-AA),22 (link),23 (link) International Society for Vascular Behavioral and Cognitive disorders (VASCOG)24 (link) and Movement Disorder Society-Task force criteria were used for diagnosis of AD, vascular dementia and Parkinson's disease dementia, respectively.25 (link) Patients fit both possible AD by NIA-AA criteria and possible major vascular cognitive disorder by VASCOG criteria were classified as mixed dementia. The 15 care needs listed in Table 1 were then assessed.

Information Of The Patients With Dementia

VariablesFrequencyPercentageData Type
GenderMale17534M
Female33366F
AgeLess than 65 years old1730
65–69 years old2041
70–74 years old56112
75–79 years old147293
80–84 years old145294
85 years old and above123245
Type of dementiaAlzheimer’s disease36372AD
Parkinson’s disease265PDD
Vascular dementia9318VaD
Mixed dementia265MD
CDRVery mild dementia104210
Mild dementia260511
Moderate dementia89182
Severe dementia55113

Abbreviation: CDR, clinical dementia rating.

The purpose of this study was to identify whether specific combinations of several care needs could be applied to particular groups of PLWD and their caregivers and thereby to provide more efficient and holistic care. That is, we intended to group the care needs for patients with dementia by gender, age, type of dementia, and dementia severity. The Apriori algorithm has been proven to be a very useful approach to discover previously unknown interesting relationships in data sets by finding rules and associations between any of the attributes by establishing support, confidence, and lift, which are defined as follows.21 ,26 ,27 (link) The support for an association rule A ⇒ B is assessed by calculating the percentage of transactions in the database containing both A and B:
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Support = P}}\left({{\rm{A}} \cap {\rm{B}}} \right)\break{\rm{ = }}{{{\rm{number}}\,{\rm{of}}\,{\rm{transactions}}\,{\rm{containing}}\,{\rm{both}}\,{\rm{A}}\,{\rm{and}}\,{\rm{B}}} \over {{\rm{total}}\,{\rm{number}}\,{\rm{of}}\,{\rm{transactions}}\,}}$$
\end{document}
The confidence of the association rule A ⇒ B is assessed by evaluating the accuracy of the rule based on the calculation of the percentage of transactions in the database containing A and also containing B simultaneously:
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Confidence = P}}\left({{\rm{B}}\left| {\rm{A}} \right.} \right){\rm{ = }}{{{\rm{P}}\left({{\rm{A}} \cap {\rm{B}}} \right)} \over {{\rm{P}}\left({\rm{A}} \right)}}\break{\rm{ = }}{{{\rm{number}}\,{\rm{of}}\,{\rm{transactions}}\,{\rm{containing}}\,{\rm{both}}\,{\rm{A}}\,{\rm{and}}\,{\rm{B}}} \over {\,{\rm{number}}\,{\rm{of}}\,{\rm{transactions}}\,\,{\rm{containing}}\,{\rm{A}}}}$$
\end{document}
Lift is a simple correlation measuring whether A and B are independent or dependent and correlated events as shown in Equation (3). If a rule has a lift of one, A and B are independent and no rule will be generated containing either event. If a rule has a lift greater than one, A and B are dependent and correlated positively. In practice, analysts tend to prefer rules with either high support or high confidence and usually both.28 In fact, strong rules will be found when certain minimum support and confidence conditions have been met.
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Lift }}\left({{\rm{A,B}}} \right){\rm{ = }}{{{\rm{P}}\left({{\rm{A}} \cap {\rm{B}}} \right)} \over {{\rm{P}}\left({\rm{A}} \right){\rm{P}}\left({\rm{B}} \right)}}$$
\end{document}
The Apriori algorithm in IBM SPSS Modeler 18 was used in this study. The notations of data type defined by numerical values or abbreviations are depicted in Table 2. The input variables for antecedents were gender, age, type of dementia, and CDR. The 15 care needs developed by our hospital were classified as both antecedents and consequents. The notations for each care need were 1 or 0. If a particular care need was applied to a patient, a value of 1 was assigned. If not, a value of 0 was used. This allowed for the identification of combinations of care needs. Minimum support, minimum confidence, and lift were set to 10%, 90%, and greater than one, respectively. The rules with higher support values indicated that the care need bundles could fulfill the majority of the patients’ needs. In contrast, the rules with relatively lower support values indicated that the care need bundles may only be applicable to a small portion of the patients, ie, special needs. The settings of antecedents and consequents in the Apriori algorithm allow the decision-maker to identify what combinations of care needs would be needed according to the specific demographic information of the patients.
Publication 2019
Blood Vessel Cognition Disorders Cognitive Impairments, Mild Dementia, Vascular Diagnosis Ethics Committees, Research Gender Memory Mixed Dementias Movement Disorders Parkinson Disease Patient Care Bundles Patients Presenile Dementia Woman
Focus groups were facilitated by experienced researchers with academic backgrounds in palliative care and health psychology and an interest in the education of healthcare professions (LS or LB), following best practice [28 ]. Another researcher or research administrator (LB or LK) attended each focus group to take field notes on environmental factors and non-verbal behaviours during and immediately after each group. The researchers and administrator were not known by participants and introduced themselves as academic researchers unconnected to the CCG or their training programme. Guidelines including maintaining confidentiality, allowing all participants to speak and there being no right or wrong answers, were explained at the beginning of each focus group. The research was part of a wider study generating data to inform future training in palliative and EoLC and its evaluation. We defined EoLC broadly as care of patients with incurable, progressive and life-limiting disease, and palliative care as an holistic approach to EoLC in line with the World Health Organization definition [29 ]. The topic guide (Table 1) was based on gaps in the existing literature, and revised with input from the project team and lay advisory group (one patient with advanced disease and four family caregivers). To prompt discussion, during the focus groups participants were given handouts listing the topics covered in a current two-day training on palliative and EoLC held in a local hospital [30 ] (Table 2), and asked to reflect on which of these would be relevant or not for GPs. The focus groups were recorded, transcribed verbatim and anonymised. Participants also completed a brief demographics form.

Topic guide

Training experience
 What sort of training, if any, have you already received regarding how to communicate with and support people with serious, life-threatening illness, and their families?

Prompts: This can include undergraduate or post-graduate training, short courses, professional development courses, etc.
Training topics [participants shown list of EoLC topics (Table 2)]
 Are there any topics that would be helpful in an EoLC training course for GPs? Why?
 Are there any topics that would not be helpful or relevant in an EoLC training course for GPs? Why not?
 Are there any topics we haven’t mentioned that you think should be included in an EoLC training course for GPs? [Explore justification for these additional items]
Preferred course format /time/ delivery
 How long should a course be? Prompts: Would you prefer shorter sessions over multiple days, or fewer longer sessions? Two days? One day?
 When should it be held? Prompt: Are particular times of day best?
 Who should attend? Prompt: Would you prefer a course attended by many different healthcare professionals or GPs only? What benefits are there to multi-professional learning? What drawbacks?
 Who should teach the course? Prompt: hospital/community palliative care staff? Other generalist providers e.g. GPs?
 How should it be taught? Prompt: in-person versus online, as lectures versus interactive skills training. What about a mixture of in-person and online resources?
 Where should it be held? Prompt: at a local hospital? Local hospice? Non-medical location?
Mentoring / ongoing supervision techniques
 Do you think that ongoing mentoring or supervision would be useful or not useful alongside an end of life care training course?

Prompts: If yes, what do you think would be the best way to provide this? What are your views of mentoring by an expert by experience, i.e. patient/family member? If you don’t think mentoring/supervision would be useful, why not?
Testing training effectiveness
 How would you feel about us assessing the effectiveness of the training course by…
  videoing or audio-recording your encounters with real or actor patients or families?
  using patient or family satisfaction measures?
  using 360° appraisals from colleagues, managers, patients and family members?
  using process outcomes, for example referral to palliative care or place of death?

Prompts: Are any of these methods particularly preferable or not preferable? Why?

Topic list

Understanding patients'/families' priorities in EoLC
Understanding your role in EoLC
Using the Amber Care Bundle [34 (link), 35 ]
Helping patients achieve their preferred place of care
Fast Track discharges [37 (link)]
Understanding and managing common symptoms in dying patients
Understanding spiritual and cultural aspects of dying
Having difficult conversations with patients and families
Understanding advance care planning and using Coordinate My Care [37 (link)]
Understanding grief and providing support for family experiencing bereavement
Publication 2017
Administrators Amber ARID1A protein, human Bereavement Family Caregivers Family Member Feelings General Practitioners Grief Health Care Professionals Hospice Care Obstetric Delivery Palliative Care Patient Care Bundles Patients Personnel, Hospital Satisfaction Supervision Teaching
Patients diagnosed with mild cognitive impairment or dementia at the memory clinic of Changhua Christian Hospital from November 2015 to June 2019 were enrolled. A total of 389 male patients with VCI were identified. International Society for Vascular Behavioral and Cognitive disorders (VASCOG) criteria were used to diagnose VCI.26 (link) Patients who met the criteria for both possible AD according to the National Institute on Aging-Alzheimer’s Association (NIA-AA)27 (link),28 (link) and possible major vascular cognitive disorders according to the VASCOG were classified as having mixed dementia, and were excluded from the study. The clinical trial was approved by the Institutional Review Board of Changhua Christian Hospital (CCH IRB 160165). The need for informed consent was waived by the Institutional Review Board of Changhua Christian Hospital because the design of the study was a retrospective data analysis. All data including assessment results (such as ADL score for Care 2, Zarit’s caregiver burden score for Care 13), and team-selected care need numbers (as listed in Table 1) were recorded in electronic medical charts with the highest confidentiality and in compliance with the Declaration of Helsinki. All data needed in the present study were extracted by our information technology department after deleting any personalized information. The demographic information of the male patients with VCI including age and clinical dementia rating (CDR) score were recorded (Table 2). A majority of the included patients were aged 75 years and older (75.3%) and had mild dementia (CDR=1, 39.3%). Subjects with a CDR score of 3 were further classified as having severe dementia and extremely severe dementia. In this study, extremely severe dementia indicated nonresponsive to external stimuli and unable to communicate, and these patients met the criteria for hospice care provided by the Taiwan National Health Insurance program.

Information of the Male Patients with VCI

VariablesFrequencyPercentageData Type
AgeLess than 65 years old358.91
65–69 years old256.42
70–74 years old369.33
75–79 years old6617.04
80–84 years old10727.55
85 years old and above12030.86
CDR0.5 (MCI or very mild dementia)14737.80
1 (Mild dementia)15339.31
2 (Moderate dementia)6115.72
3 (Severe dementia)276.93
3 (Extremely severe dementia)¥10.34

Note:¥Extremely severe dementia: subjects are unable to communicate and nonresponsive to external stimuli.

Abbreviations: CDR, clinical dementia rating; MCI, mild cognitive impairment.

The aim of this study was to identify care need combinations for male patients with VCI and their caregivers in order to provide holistic care since patients with different ages and dementia severity may need different combinations of care needs. The Apriori algorithm was used to identify statistical correlations among attributes by setting up support, confidence, and lift.17 (link),25 (link) Jhang et al17 (link) and Lin et al25 (link) previously reported that the Apriori algorithm was a very effective approach to identify care bundles for patients with dementia and their caregivers. Therefore, we used the Apriori algorithm in this study. The descriptions of support, confidence, and lift are as follows.17 (link),25 (link),29 (link) The support of A ⇒ B is calculated by the percentage of transactions consisting of both A and B in the database expressed by Equation (1):
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Support}}\; = \;P\left({A \cap B} \right)\; = \;{{{\rm{number\,of\,transactions\,containing\,both\,A\,and\,B}}} \over {{\rm{total\,number\,of\,transactions}}}}$$
\end{document}
The confidence of A ⇒ B is to compute the accuracy of the rule based on the proportion of transactions in the database containing A and also containing B simultaneously depicted in Equation (2):
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Confidence}}\;{\rm{ = }}\;P\left({B\left| A\right.} \right)\; = \;{{P\left({A \cap B} \right)} \over {P\left(A \right)}}$$
\end{document}
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$ = {{{\rm{number\,of\,transactions\,containing\,both\,A\,and\,B}}} \over {{\rm{number\,of\,transactions\,containing\,A}}}}$$
\end{document}
Lift in Equation (3) is to measure the correlation between A and B. If a lift is one, A and B are statistically independent indicating no rule will be generated containing either event. In contrast, if a lift is larger than one, A and B are dependent and positive correlated. In practice, analysts tend to prefer rules with either high support or high confidence, and usually both.30
\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$${\rm{Lift}}\left({A,\;B} \right)\; = \;{{P\left({A \cap B} \right)} \over {P\left(A \right)P(B)}}$$
\end{document}
The Apriori algorithm in IBM SPSS Modeler 14.1 was used, and the notations of data type in age and CDR are depicted in Table 2. The input variables for antecedents were age and CDR. The 15 care needs described in Table 1 and developed by the dementia collaborative care team at Changhua Christian Hospital were classified as both antecedents and consequents. In doing so, the analyst could identify whether there was any association between the care need combinations and age and CDR of the male patients with VCI. The notations for each care need adopted a binary data set, i.e., 0 and 1. If a particular care need was applied to a patient, a value of 1 was assigned. If not, a value of 0 was used. Minimum support, minimum confidence, and lift were set to 10%, 90%, and greater than one, respectively. The rules with higher support values were care bundles that could fulfill the majority of the patients’ needs. On the other hand, the rules with relatively lower support values were the care bundles that may only be applicable to a small portion of the patients, i.e., special needs.17 (link),25 (link)
Publication 2020
Blood Vessel Caregiver Burden Cognition Disorders Cognitive Impairments, Mild Diagnosis Ethics Committees, Research Hospice Care Males Memory Mixed Dementias National Health Insurance National Health Programs Patient Care Bundles Patients Presenile Dementia
The institution's Chief Nursing Officer (CNO) was the first administrator that was contacted regarding the possibility of implementing the ABCDE bundle into everyday care, followed by the Critical Care Medical Director. Incorporating the Medical Directors' feedback, the research team developed the initial implementation plan. This interprofessional team met on numerous occasions to discuss: how key stakeholders may perceive the bundle, educational strategies (e.g. computer based, in person, etc.), marketing strategies (e.g. with graphics, pocket cards, etc.), evaluation strategies, methods of outcomes assessment, and communication strategies. The research team then collaborated with hospital administrators to identify and formally appoint interdisciplinary (i.e., nursing, PT, RT, pharmacy, and physicians trained in various specialties) ABCDE bundle implementation leaders. While numerous implementation leaders were identified, the most active members included the ICU nursing director, a lead RT, one medical and one surgical CCS physician, an ICU-based PT, 2 pharmacists, 2 assistant nurse managers, and a neurosurgeon with extensive ICU experience.
All implementation leaders received a file that described the bundle and supporting studies. We also provided the proposed delirium and sedation/agitation screening tools and resources. The implementation leaders were expected to become familiar with the ABCDE bundle prior to the initial group meeting. At this meeting, the research team and implementation leaders discussed the ABCDE bundle and attempted to identify existing institutional policies related to sedation/analgesia, alcohol withdrawal, ventilator management, and mobility that would support or conflict with the ABCDE bundle. At subsequent meetings, the group discussed the bundles' evidence strength and quality, the relative advantages and disadvantages of change, perceived ABCDE bundle complexity/quality, and potential costs and barriers associated with bundle implementation.
Next we identified unit-level leaders. This group included ICU nurse managers, CCS NPs/PAs, nurse educators, the director of respiratory care, an additional ICU pharmacist, other CCS physicians, and members of the performance improvement team. Numerous meetings discussed the same topics as those held with the formal implementation leaders. Each of the unit-level leaders was then asked to identify staff that they thought may be willing to serve as ABCDE bundle champions. The research team then incorporated staff feedback and began the process of developing, obtaining, and distributing educational resources. These resources included a number of different informational posters/flyers, unit-level ABCDE bundle resource manuals, unit and specialty based in-services, and CAM-ICU and RASS pocket cards.
Publication 2013
Administrators ARID1A protein, human Critical Care Delirium Ethanol Faculty, Nursing Hospital Administrators Management, Pain Neurosurgeon Nurse Managers Operative Surgical Procedures Patient Care Bundles Physician Executives Physicians Range of Motion, Articular ras Oncogene Respiratory Rate Sedatives

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2022
Awareness Blood Pressure CTSB protein, human Drug Labeling Kidney Kidney Failure Patient Care Bundles Patients Physician Assistant Physicians Practitioner, Nurse Reading Frames Survivors

Most recents protocols related to «Patient Care Bundles»

Search results were assessed in a two-stage process. Records were imported to EndNote (V.20.1, Clarivate Analytics, Philadelphia, USA) and, after duplicate removal, imported to Rayyan.35 (link) Two authors (NP and ERB) independently screened titles and abstracts using Rayyan’s blinding option. Additionally, we conducted a hand search of reference lists of all included studies and relevant reviews identified in the screening to find additional literature. Two authors (NP and ERB) independently assessed the full texts of the remaining records. Disagreements between authors were solved through discussions. Reasons for exclusion were documented (online supplemental table S2).
Inclusion criteria were as follows: (1) participants were ≥18 years; (2) more than 50% of the patients received ICU treatment; (3) an ICU care bundle (≥3 bundled measures) was compared with standard care; (4) patient-relevant outcomes were measured at ICU discharge or later; (5) original research article; (6) published in English, German or Spanish. Exclusion criteria were as follows: (1) paediatric patients; (2) no measurement of patient-relevant outcomes at ICU discharge or later; (3) records were based on expert opinion or secondary research only.
Publication 2023
Hispanic or Latino Patient Care Bundles Patient Discharge Patients
Clinically relevant information, including age, body mass index, smoking status, comorbidity (diabetes), types of surgery, surgical care bundle measures, SSI, microbiological cultures, chemo-radiotherapy, tumour biology, reoperations, postoperative thromboembolic events, seroma aspirations, length of stay and time to start of adjuvant treatments, were registered retrospectively.
Publication 2023
Aspiration, Psychology Diabetes Mellitus Index, Body Mass Neoplasms Operative Surgical Procedures Patient Care Bundles Pharmaceutical Adjuvants Radiotherapy Repeat Surgery Seroma Thromboembolism
The primary aim was to investigate the impact of SCB in reducing SSI using a multivariate analysis, adjusting for patient and tumour characteristics. This was a retrospective cohort study of patients who underwent non-reconstructive-related breast cancer surgery between January 2016 and December 2020 at Sahlgrenska University Hospital, Sweden. The SCB was implemented in October 2018. The period between November 2018 and January 2019 was considered an early SCB introductory phase and therefore excluded from the study. Patients with SSIs were identified through investigation of the electronic medical records (Melior) as well as by searching the Cognos AnalyticsTM hospital database using infection International Classification of Diseases (ICD) code T81.4.
The primary outcome measurement was 30-day postoperative SSI adjusted for age, BMI, smoking, diabetes, types of surgery, NACT and seroma aspirations. Surgical site infection was diagnosed according to the Centre for Disease Control and Prevention criteria that include presence of erythema, localized swelling, pain, purulent discharge with or without fever, or positive bacterial culture, as well as diagnosis being made by a qualified physician [20 ]. Adequate surgical care bundle adherence was defined to be present if a patient received at least six of the eight measures described in the bundle protocol. Secondary outcome measurements for possible adverse events were defined at 30 days postoperatively.
The following operative ICD breast surgery codes HAB00, HAB40, HAC10, HAC15, HAC20, HAC22, HAC30, HAD30, HAF00, HAC99 and ZZR70, in combination with axillary surgery codes PJA10, PJD42 and PJD52, were used for searching the hospital database system (Cognos AnalyticsTM).
The inclusion process from all patients undergoing surgery during the study period was conducted in three consecutive stages: firstly, all NACT patients who underwent surgery were included, followed by all non-NACT patients who had breast operations combined with axillary clearances. Lastly, as the proportion of SLNB amongst the non-NACT group were predominantly larger than the axillary clearance, a random selection of those who had a breast operation with SLNB was conducted (Figure 1).
Publication 2023
Aspiration, Psychology Axilla Bacteria Breast Diabetes Mellitus Diagnosis Erythema Fever Infection Malignant Neoplasms Mammaplasty Neoplasms Operative Surgical Procedures Pain Patient Care Bundles Patient Discharge Patients Physicians Seroma Surgical Wound Infection Thoracic Surgical Procedures
The evidence-based care bundle of FeSS Protocols (Table 2) refined from our previous FeSS implementation studies [1 (link), 2 (link)] will be used in this national translational study.

Summarised elements of the Fever, Hyperglycaemia (Sugar) Swallow (FeSS) Protocols

Fever (n=2)

• Temperature readings monitored and recorded at least four times per day for the first 72 h

• If temperature => 37.5°C treat with paracetamol or other anti-pyretic

Sugar (Hyperglycaemia) (n=3)

• Formal venous glucose on admission to Emergency Department or stroke service

• Blood glucose level readings monitored and recorded at least four times per day for the first 48 h, to continue for 72 h if BGL unstable

• If blood glucose level >10 mmol/L (180mg/dl) treat with insulin

Swallowing (n=2)

• Swallow screen or swallow assessment within 4 h of admission and prior to being given oral food, drink, or medications

• Referral to speech pathologist for full assessment for those who fail the swallow screen

Publication 2023
Acetaminophen Blood Glucose Carbohydrates Cerebrovascular Accident Fever Food Glucose Hyperglycemia Pathologists Patient Care Bundles Pharmaceutical Preparations Protein Biosynthesis Speech Veins
The intervention constituted of a care bundle (Table 1), that addressed different aspects of post-operative EVD care: head dressing, frequency of CSF sampling, handling of CSF sampling, treatment of meningitis and EVD flushing.

The intervention bundle and differences when compared to the pre-protocol phase

Area of interventionPre-protocolPost-protocol
Head dressingNo formal recommendationSterile dressing as long as EVD remains in situ, changed every 72 hours, except for cases where EVD malfunction or hemorrhage is suspected.
CSF tappingDaily CSF tappingOnly when all other infection foci have been excluded and there are clinical symptoms that suggest meningitis
Handling of CSF tappingNo formal recommendationSterile gloves, multiple disinfection moments before tapping
Meningitis treatment strategyNo formal recommendationMultidisciplinary meetings with infectiologists
EVD flushingNo formal recommendationUse of sterile gloves, multiple disinfection moments
Cerebrospinal fluid (CSF) would be sampled according to a written protocol, at the time of insertion, when infection is suspected, 48–72 hours after initiation of antibiotic treatment, and upon removal of the EVD.
In the pre-protocol period CSF would be routinely sampled three times a week. In the post-protocol era, CSF would only be collected in case meningitis was strongly suspected based on clinical symptoms and other infection foci had been excluded.
The CSF samples would be collected via the proximal 3-way needleless stopcock by a neurosurgical trainee or physician assistant following strict aseptic measures. The rubber sealed cap would be disinfected with alcohol 70% and a total of 5 mL CSF would be sampled and sent to the medical microbiology laboratory for Gram’s stain, culture, cell count, and for chemical analyses on glucose, and protein concentration. Catheters were left in place if clinically indicated and changed only if they malfunctioned or in cases of highly potent infections. Infection treatment strategies were discussed regularly during multidisciplinary meetings with the infectious disease specialists. Drain blockage would usually be resolved by flushing the drain with 2 mL sterile 0.9% NaCl, following the same aseptic protocol.
Publication 2023
Antibiotics Asepsis Catheters Communicable Diseases Disinfection Ethanol Glucose Gram's stain Head Hemorrhage Infection Meningitis Normal Saline Patient Care Bundles Physician Assistant Postoperative Care Proteins Rubber Specialists Sterility, Reproductive

Top products related to «Patient Care Bundles»

Sourced in United States
Cyto-Chex is a sample collection and stabilization product designed for flow cytometry applications. It is used to collect, preserve, and stabilize cellular samples, ensuring the integrity of cells and their surface markers for analysis.
Sourced in United States
SPSS for Mac is a statistical software package developed by IBM. It provides tools for data analysis, data management, and data visualization. The software is designed to run on Apple's macOS operating system.
Sourced in France, United States, Germany, Italy, United Kingdom, Canada, Poland, Macao
The Vitek 2 is a compact automated microbiology system designed for the identification and antimicrobial susceptibility testing of clinically significant bacteria and yeasts. The system utilizes advanced colorimetric technology to enable rapid and accurate results for clinical decision-making.
Sourced in United States, United Kingdom
EndNote is a reference management software that enables users to collect, organize, and format bibliographic citations. It allows users to easily insert citations and create bibliographies in various citation styles for use in research papers, articles, and other academic documents.
Sourced in Germany
Etomidate-Lipuro is an intravenous anesthetic agent developed by B. Braun. It is a short-acting hypnotic medication used for the induction and maintenance of general anesthesia.
Sourced in United States, Germany, Japan, United Kingdom, Belgium, Australia, Austria, Poland, China, Italy
SPSS Statistics 23 is a software package used for statistical analysis. It provides a wide range of statistical and graphical techniques to analyze and visualize data. The core function of SPSS Statistics 23 is to enable users to perform data management, analysis, and presentation tasks.
Sourced in United States, Japan, Hong Kong
PASW Statistics software is a comprehensive suite of data analysis tools used for statistical analysis, data management, and visualization. It provides a wide range of statistical techniques for various research and business applications. The software is designed to help users interpret data, identify trends, and make informed decisions.

More about "Patient Care Bundles"

Patient Care Bundles, also known as Care Bundles or Clinical Bundles, are evidence-based sets of interventions that, when implemented together, can significantly improve patient care and outcomes.
These bundled approaches typically include a collection of best practices targeting specific clinical conditions or care processes, such as sepsis management, ventilator-associated pneumonia (VAP) prevention, or central line-associated bloodstream infection (CLABSI) reduction.
By applying a bundled approach, healthcare providers can enhance patient safety, reduce complications, and promote better overall health.
PubCompare.ai's innovative platform enables seamless research and identification of the most effective Patient Care Bundles from literature, pre-prints, and patents, helping to drive improved patient outcomes.
The use of Patient Care Bundles has been shown to be effective in a variety of healthcare settings, including acute care, long-term care, and outpatient settings.
For example, the Vitek 2 system has been used to identify and monitor the implementation of Patient Care Bundles for sepsis management, while SPSS Statistics 23 and PASW Statistics software have been utilized to analyze the impact of these bundles on patient outcomes.
Additionally, tools like Cyto-Chex and EndNote can be used to streamline the research and documentation process when working with Patient Care Bundles.
Etomidate-Lipuro, a medication used in the management of sepsis, may also be incorporated into certain Patient Care Bundles.
By leveraging the power of PubCompare.ai's platform and incorporating the latest evidence-based practices, healthcare providers can optimize their patient care protocols and drive significant improvements in patient safety, quality of care, and overall health outcomes.